LANDORE RESOURCES LIMITED

Net Asset Value • Aug 5, 2025

National Storage Mechanism | Additional information

RNS Number : 0950U

Landore Resources Limited

05 August 2025

5 August 2025

Landore Resources Limited

Result of Annual General Meeting

London, United Kingdom - 5 August 2025 - Landore Resources Limited (AIM: LND) ("Landore Resources" or the "Company") is pleased to announce that at the Company's Annual General Meeting ("AGM"), held earlier today, all of the proposed resolutions as set out in the formal Notice of AGM dated 27 June 2025 were duly passed by shareholders.

- ENDS -

For further information, please contact : Landore Resources Limited Alexander Shaw (CEO) or engage with the company directly	[email protected] https://investors.landore.com/s/051b30
Strand Hanson Limited (Nominated Adviser and Joint Broker) James Dance/Matthew Chandler/Robert Collins	Tel: 020 7409 3494
Hannam & Partners (Joint Broker) Andrew Chubb/Matt Hasson	Tel: 020 7907 8500
Burson Buchanan (Financial PR) Bobby Morse/Oonagh Reidy	[email protected] Tel: 020 7466 5000

Subscribe to our news alert service : https://investors.landore.com/auth/signup

About Landore Resources

Landore Resources (AIM: LND) is the 100% owner of the highly prospective BAM Gold Project, Northwestern Ontario, Canada, which has an NI 43-101 compliant resource estimate of 1.5 Moz Au (Indicated: 1.03 Moz from 30.96Mt @ 1.0g/t; Inferred: 467,000oz from 18.3M/t @ 0.8g/t). Ontario is Canada's largest gold producing province, and produced 3.9 Moz, accounting for 41% of Canada's total gold production in 2023. Landore Resource's strategic objective is to crystallise value from BAM Gold's last estimated NPV of US$333.6m @ US$1,800/oz spot (from May 2022 PEA), as well as generating additional value from its non-core portfolio of precious and battery metals projects in eastern Canada and the USA.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RAGSSAFIIEISESA